Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results

Reset filter

Keywords

Clinical Chemistry Tests ×

Women ×

Show more Keywords

Select data models

Selected data models

You must log in to select data models for download or further analysis.

1 Search results.

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032 - Period 1 Day 20-21 (Visit 140-150): Vital Signs, Drug Administration, ECG, Laboratory Tests

- 12/24/18 - 1 form, 18 itemgroups, 91 items, 1 language

Itemgroups: Administrative data,Vital Signs,Duplicate 1,Duplicate 2,Study Drug Administration,Hematology Test,Chemistry Test,UA / Urine Chemistry Test,Pharmacokinetic Blood Collection,Period 1 - Day 21,Vital Signs,Duplicate 1,Duplicate 2,Electrocardiogram,Overall Interpretation of ECG,Study Drug Administration,Pharmacodynamic Blood Connection,Pharmacokinetic Blood Collection 12 hr span

Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Keywords

Table of contents

Selected data models

1 Search results.

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032 - Period 1 Day 20-21 (Visit 140-150): Vital Signs, Drug Administration, ECG, Laboratory Tests

Contact

Help